Summit Therapeutics Announces 19.72M Share Offering by Selling Stockholders
- ByInvesting.com-
Summit Therapeutics (NASDAQ:SMMT) has filed for up to 19,720,291 share offering by selling stockholders.
Symbol | Exchange | Currency |
|---|
Summit Therapeutics (NASDAQ:SMMT) has filed for up to 19,720,291 share offering by selling stockholders.
Investing.com - Summit Therapeutics PLC (NASDAQ: SMMT) reported first quarter EPS of $-0.070, $0.19 better than the analyst estimate of $-0.260. Revenue for the quarter came in at...
Summit Therapeutics (NASDAQ:SMMT) reported Q4 EPS of (GBP0.07), GBP0.19 better than the analyst estimate of (GBP0.26).
Summit Therapeutics plc (NASDAQ:SMMT) has been struggling lately, but the selling pressure may be coming to an end soon. That is because SMMT recently saw a Hammer Chart Pattern...
As of late, it has definitely been a great time to be an investor Summit Therapeutics plc (NASDAQ:SMMT) .The stock has moved higher by nearly 23.2% in the past month, while it is...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) announced that it has entered into an strategic agreement with Fargo, ND-based plasmid DNA manufacturer, Aldevron for the supply of...
Summit Therapeutics Inc., a biopharmaceutical company, research and develops primarily oncology therapies in the United States, and the United Kingdom. The company’s product pipeline includes SMT-738, a novel class of precision antibiotics for treatment which is in preclinical stage for the treatment of multidrug resistant infections, which primarily includes carbapenem-resistant Enterobacteriaceae infections. It has a collaboration and license agreement with Akeso, Inc. for research and develop Ivonescimab (AK112) and SMT112, a bispecific antibody for immunotherapy through blockade of PD-1 with the anti-angiogenesis. The company was founded in 2003 and is headquartered in Cambridge, Massachusetts.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Sell | Strong Sell | Strong Sell | Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 195.28 | 197.33 | 194.42 | +1.40 | +0.72% | 109.50M | NASDAQ | |||
| 162.36 | 162.47 | 161.27 | +1.59 | +0.99% | 46.76M | NASDAQ | |||
| 61.85 | 62.09 | 61.66 | -0.01 | -0.02% | 8.35M | NYSE | |||
| 207.84 | 208.09 | 202.82 | +2.49 | +1.21% | 22.53M | NASDAQ | |||
| 100.89 | 101.15 | 99.78 | -0.50 | -0.49% | 32.74M | NASDAQ | |||
| 284.05 | 284.46 | 281.48 | +3.54 | +1.26% | 24.97M | NASDAQ | |||
| 40.38 | 40.49 | 40.25 | +0.13 | +0.32% | 12.49M | NYSE | |||
| 97.88 | 99.53 | 97.25 | +1.79 | +1.86% | 58.34M | NASDAQ | |||
| 102.00 | 103.04 | 101.01 | +1.75 | +1.75% | 51.96M | NASDAQ | |||
| 162.67 | 164.50 | 162.41 | +0.54 | +0.33% | 1.16M | NASDAQ | |||
| 273.83 | 274.99 | 271.02 | +3.99 | +1.48% | 35.62M | NASDAQ | |||
| 8.15 | 8.38 | 8.05 | -0.07 | -0.85% | 20.57M | NYSE | |||
| 101.32 | 101.61 | 100.29 | -0.58 | -0.57% | 24.17M | NASDAQ | |||
| 46.51 | 47.32 | 46.02 | -0.19 | -0.41% | 12.10M | NYSE | |||
| 51.43 | 51.68 | 51.13 | +0.26 | +0.51% | 11.42M | NASDAQ |